In the present study, while we clearly demonstrated that p53 is implicated in leptin-induced increase in FoxO3A expression in hepatic cancer cells, detailed mechanisms underlying are not clearly understood and additional studies are required to elucidate the interaction between p53 and FoxO3A in leptin-treated cancer cells. The gene discussed is FOXO3; the disease is cancer.